FSBI "ARRIAH" received a positive decision to issue a patent "Method of producing a polyvalent vaccine against equine leptospirosis"

Due to the use of an innovative drug based on a high-molecular polyacrylic polymer dispersed in water as an adjuvant, the vaccine drug has a reduced reactogenicity on a living organism , which has been proven by studies on naturally susceptible animals and allows one to avoid negative consequences from vaccination .

Leptospirosis (lat. Leptospirosis) is a natural focal infectious disease of humans and animals, of bacterial etiology, related to ubiquitous infections.

In Russia, the epizootic situation regarding leptospirosis remains tense. The difficulty of vaccinating horses against this disease lies in the high risk of edema in the form of swelling at the site of injection of the drug, which makes it difficult to feed and water animals and even their movement, allergic complications, which together lead to a decrease in the performance of farm horses and the disqualification of sports individuals participating in competitive events.

Currently, the institution’s specialists are forming a registration dossier to enable full-scale production and sale of the developed drug.